Shares Magazine
10.50p+0.04 (+0.38%)31 Mar 2025, 15:52
Jump to:
Futura Medical PLC Fundamentals
| Company Name | Futura Medical PLC | Last Updated | 2025-03-31 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 303.830 m | Market Cap | £31.90 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.02 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | 1.2122 | Cash Equity Ratio | 0.5020 |
| Quick Ratio | 3.3226 | Current Ratio | 3.75 |
| Price To Book Value | 4.0850 | ROCE | 0 |
Futura Medical PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Futura Medical PLC Company Financials
| Assets | 2023 | 2022 |
|---|---|---|
| Tangible Assets | £2.48 m | £1.16 m |
| Intangible Assets | 0 | 0 |
| Investments | 0 | 0 |
| Total Fixed Assets | £2.48 m | £1.16 m |
| Stocks | £339.00 | 0 |
| Debtors | £1.15 m | £70,114.00 |
| Cash & Equivalents | £7.71 m | £4.03 m |
| Other Assets | 0 | 0 |
| Total Assets | £11.82 m | £6.47 m |
| Liabilities | 2023 | 2022 |
|---|---|---|
| Creditors within 1 year | £6.34 m | £1.75 m |
| Creditors after 1 year | 0 | 0 |
| Other Liabilities | 0 | 0 |
| Total Liabilities | £6.34 m | £1.75 m |
| Net assets | £5.48 m | £4.72 m |
| Equity | 2023 | 2022 |
|---|---|---|
| Called up share capital | £602,812.00 | £576,093.00 |
| Share Premium | £71.07 m | £66.55 m |
| Profit / Loss | -£6.89 m | -£6.87 m |
| Other Equity | £5.48 m | £4.72 m |
| Preference & Minorities | 0 | 0 |
| Total Capital Employed | £5.48 m | £4.72 m |
| Ratios | 2023 | 2022 |
|---|---|---|
| Debt Ratio | 0 | 0 |
| Debt-to-Equity | 0 | 0 |
| Assets / Equity | 1.2122 | 1.2122 |
| Cash / Equity | 0.5020 | 0.5020 |
| EPS | -£0.02 | -£0.02 |
| Cash Flow | 2023 | 2022 |
|---|---|---|
| Cash from operating activities | £570,253.00 | -£5.78 m |
| Cashflow before financing | £5.12 m | -£5.61 m |
| Increase in Cash | £3.69 m | -£6.35 m |
| Income | 2023 | 2022 |
|---|---|---|
| Turnover | £3.10 m | 0 |
| Cost of sales | £1.33 m | 0 |
| Gross Profit | £1.77 m | 0 |
| Operating Profit | -£6.96 m | -£6.87 m |
| Pre-Tax profit | -£6.89 m | -£6.87 m |
Futura Medical PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives a majority of its revenue from the United Kingdom and the European Union. |
| Latest Interim Date | 10 Sep 2024 |
| Latest Fiscal Year End Date | 10 Apr 2024 |
Futura Medical PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2025-01-13 | Mr. Jeffrey Robert Needham | Non-Executive Director,Chairman |
| 2023-07-18 | Mr. John Milne Clarke | Non-Executive Director,Chairman |
| 2016-03-31 | Ms. Lisa Arnold | Non-Executive Director |
| 2012-02-01 | Dr. William Duncan Potter | Executive Director,Chairman |
| 2025-01-13 | Mr. Andrew Vaughan Unitt | Non-Executive Director,Senior Independent Director |
| 2024-09-13 | Mr. James Henry Barder | Executive Director,Chief Executive |
| 2021-12-29 | Mr. Jonathan David Freeman | Non-Executive Director,Senior Independent Director |
| 2015-03-28 | Mr. David Bryn Davies | Executive Director,Chief Development Officer |
| 2018-04-09 | Mr. Derek Adrian Martin | Executive Director,Finance Director and Company Secretary |
| 2011-08-09 | Mr. Anthony Louis Clayden BSc,FCA,MSI | Executive Director,Finance Director and Company Secretary |
| 2024-09-13 | Mr. Kenneth William James | Executive Director,Head of RandD |
| 2024-04-29 | Ms. Angela Hildreth | Executive Director,Finance Director, Chief Operating Officer and Company Secretary |
| 2025-01-13 | Mr. Gordon Roy Davis | Non-Executive Director |
Futura Medical PLC Contact Details
| Company Name | Futura Medical PLC |
|---|---|
| Address | 40 Occam Road, Surrey Technology Centre, Guildford, GU2 7YG |
| Telephone | +44 1483685670 |
| Website | https://www.futuramedical.com |
Futura Medical PLC Advisors
| Auditor | KPMG |
|---|---|
| Phone | +44 1189642000 |
| Fax | +44 1189642222 |
| Bank | HSBC Bank PLC |
|---|
| Solicitor | Withers & Rogers LLP |
|---|---|
| Phone | +44 2079403600 |
| Fax | +44 2073789680 |
| Stockbroker | N+1 Singer |
|---|---|
| Phone | +44 2074963000 |
| Fax | +44 2074963150 |
| Nominated Adviser | N+1 Singer |
|---|---|
| Phone | +44 2074963000 |
| Fax | +44 2074963150 |
| Registrar | Capita Asset Services |
|---|---|
| Phone | +44 8716640300 |
| Fax | +44 2086392342 |
| Financial PR Adviser | Buchanan |
|---|---|
| Phone | +44 2074665000 |
| Fax | +44 2074665001 |
| Solicitor | Memery Crystal |
|---|---|
| Phone | +44 2072425905 |
| Fax | +44 2072422058 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Aston Martin Lagonda Global Holdings PLC | 69.85 | 7.05 |
| British American Tobacco PLC | 3,182.00 | 1.86 |
| Moonpig Group PLC | 210.00 | 1.69 |
| Severn Trent PLC | 2,531.00 | 1.40 |
| Harbour Energy PLC | 210.30 | 1.40 |
| Imperial Brands PLC | 2,865.00 | 1.38 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Pets AT Home Group PLC | 216.40 | -8.46 |
| Molten Ventures PLC | 256.50 | -7.73 |
| Close Brothers Group PLC | 278.20 | -7.20 |
| International Consolidated Airlines Group S.A. | 260.80 | -6.62 |
| Raspberry Pi Holdings PLC | 466.60 | -6.27 |
| Mobico Group PLC | 58.15 | -6.06 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.